Navigation Links
ANI Pharmaceuticals Announces an Agreement for the Development and Marketing of an Oral Soft Gel Prescription Product with Sofgen Pharmaceuticals
Date:8/12/2013

BAUDETTE, Minn., Aug. 12, 2013 /PRNewswire/ -- ANI Pharmaceuticals (NASDAQ: ANIP) today announced that it has signed a binding letter of intent for the development of an oral soft gel prescription product with Sofgen Pharmaceuticals ("Sofgen.") The product, indicated for cardiovascular health, will be the subject of an Abbreviated New Drug Application ("ANDA") filing. Sofgen will be responsible for the development, manufacturing and regulatory submission of the product and ANI will be responsible for marketing and distribution in the United States.

Arthur S. Przybyl, ANI's President and CEO stated, "I am pleased to have entered into this collaboration with Sofgen for an oral soft gel drug.  In addition to our internal product development efforts, we will continue to pursue opportunities through external partnerships and acquisitions in order to leverage our core capabilities in manufacturing and marketing.  We are fortunate to have such a high quality partner in Sofgen."

About ANI

ANI is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies. Over the last two years ANI has launched three new products and has twelve products in development. ANI's targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities
'/>"/>

SOURCE ANI Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Announces Continuance
2. Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results
3. ANI Pharmaceuticals Reports Net Revenues of $6.2 million and adjusted non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013
4. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
5. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
6. EpiCept Stockholders Overwhelmingly Approve Final Conditions to Merger with Immune Pharmaceuticals Ltd.
7. Isis Pharmaceuticals to Present at the Canaccord Genuity 33rd Annual Growth Conference
8. Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results
9. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
10. Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference
11. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  ResMed Inc. (NYSE: RMD ) today announced ... the quarter was $423.0 million, a 10 percent increase compared ... increase on a constant currency basis). Net income was $91.2 ... ended December 31, 2013. Diluted earnings per share for the ...
(Date:1/22/2015)... 22, 2015  Bio-Techne Corporation (NASDAQ: TECH ) ... member of the new Simple Plex platform through its ... represents the re-branding of the previously acquired CyPlex instrument ... is a transformative immunoassay technology which integrates an innovatively ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/3h534b/infectious ) ... Diagnostics Market by Product, Application, Technology, End User - ... , The infectious disease diagnostics market is ... $18,156.2 million by 2019 from $12,422.8 million in 2014. ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... Fla., Nov. 18 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: ... phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) ... in Orlando, FL,(1,2) with ONSET/OFFSET study results being simultaneously ... The ONSET/OFFSET data showed that treatment with ...
... , MADISON, N.J., Nov. 18 Quest Diagnostics Incorporated (NYSE: ... and services, today announced that the Simplexa Influenza A H1N1 (2009) ... and is now available as a test kit for distribution to ... at MEDICA 2009, November 18 to 21, 2009, at the Dusseldorf ...
Cached Medicine Technology:Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body 2Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body 3Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA(TM)) and How it Works in the Body 42009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name 22009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name 32009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name 42009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name 5
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
(Date:1/22/2015)... January 22, 2015 IsoComforter, Inc. has introduced ... with patented IsoTube design to treat specific body parts and ... most progressive and easy to use patented cold therapy machine ... sports related orthopedic and muscle injuries. IsoComforter has become ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
Breaking Medicine News(10 mins):Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Campaign for Cancer Prevention (CCP) began in,2007 with the ... care about preventing cancer. It has now,grown to a ... initiative on the social media,platform, Causes.com. Nearly five years ... Women,s,Hospital (BWH), a Harvard Medical School flagship teaching hospital, ...
... male breast cancer is low and most men do not even ... new research from the University of Leeds. Breast cancer ... diagnoses in women in the UK each year. However around 340 ... cancer each year and around 70 men will die. Funded ...
... WASHINGTON, Oct. 3In a feat of technology tweaking that ... University of California, Davis has transformed everyday iPhones into ... cost about as much as a typical app, the ... to perform detailed microscopy and spectroscopy. The team ...
... the University of Bristol, has found that children who are ... more filling. This finding, published (online ahead of print) in ... because it reveals one way in which children over-consume snack ... are at risk of obesity due to consumption of energy-rich ...
... HealthDay Reporter , FRIDAY, Sept. 30 (HealthDay News) ... effective as psychiatric drugs in reducing the agitation that ... suggests. In a three-month period, nursing home residents ... involving music, mime and humorous props showed a significant ...
... accepted for publication in The Endocrine Society,s Journal ... shift work at a young age is associated ... Previous studies have shown that long-term elevated cortisol ... and cardiovascular risk. Shift work, defined as ...
Cached Medicine News:Health News:Campaign for Cancer Prevention connects 6 million+ members on Facebook Causes to research at BWH 2Health News:Campaign for Cancer Prevention connects 6 million+ members on Facebook Causes to research at BWH 3Health News:Researchers call for more awareness of male breast cancer as cases rise 2Health News:Researchers call for more awareness of male breast cancer as cases rise 3Health News:Researchers transform iPhone into high-quality medical imaging device 2Health News:Researchers transform iPhone into high-quality medical imaging device 3Health News:Researchers transform iPhone into high-quality medical imaging device 4Health News:New study finds familiarity increases the fullness that children expect from snack foods 2Health News:Laughter Might Be Good Medicine for Alzheimer's Patients 2Health News:Laughter Might Be Good Medicine for Alzheimer's Patients 3
Can download data from your A&D balance directly to your PC saving time and reducing the chances of manually recording the wrong weighing data; 60 month warranty; automatic adjustable environment set...
... is a fully automated genetic analysis system. ... with a patented linear polyacrylamide (LPA) gel, ... voltage program, and analyzes the data. Software ... and even customize automated data assessment. All ...
Coated-Tube (CT) RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum...
... an 125I radioimmunoassay designed for,in ... quantitative,measurement of estradiol in serum, ... in girls,and gynecomastia in men, ... amenorrhea. It is,also intended for ...
Medicine Products: